Company / Operating Income
ANI Pharmaceuticals, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$111.1M
FY2025
5-year range
-$39.8M / $111.1M
FY2021-FY2025
Trend
+18922.8%
vs FY2024
Sector context
#34 of 204
Health Care
What the data says
Operating Income changed +18923% YoY in FY2025, a notable deviation from the 9-year average annual change of +2082%.
Based on SEC 10-K filings.
$111M in FY2025. Top quartile in the Health Care sector.
Improved from $47M to $111M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 204This company $111.1M Sector average $107.7M
▼
+3.1% above sector average
Key checks
Key Insights
- In FY2025, operating income increased 18922.8% year-over-year.
- Ranks #34 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.1M | +18922.8% |
| FY2024 | $584.0K | -98.8% |
| FY2023 | $47.0M | +233.1% |
| FY2022 | -$35.3M | +11.3% |
| FY2021 | -$39.8M | -148.5% |
| FY2020 | -$16.0M | -198.0% |
| FY2019 | $16.4M | -53.8% |
| FY2018 | $35.4M | +24.8% |
| FY2017 | $28.3M | +41.1% |
| FY2016 | $20.1M | +2136.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026